宏源药业：部分高管董事所持有的首发前限售股于2024年9月20日届满限售期上市流通

Core Viewpoint - Hongyuan Pharmaceutical's executives indicated that some of their pre-IPO restricted shares will become tradable on September 20, 2024, following the expiration of the lock-up period [2]. Summary by Relevant Sections - Executive Shareholding: The company stated that during the tenure of the executives, 25% of their total shareholdings will be unlocked annually, while the remaining 75% will remain locked automatically [2].